- Home
- JHI vs RPID Comparison
JHI vs RPID Comparison
Compare JHI & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JHI
- RPID
- Stock Information
- Founded
- JHI 1971
- RPID 2006
- Country
- JHI United States
- RPID United States
- Employees
- JHI N/A
- RPID N/A
- Industry
- JHI Trusts Except Educational Religious and Charitable
- RPID Medical Specialities
- Sector
- JHI Finance
- RPID Health Care
- Exchange
- JHI Nasdaq
- RPID Nasdaq
- Market Cap
- JHI 125.7M
- RPID 106.5M
- IPO Year
- JHI N/A
- RPID 2021
- Fundamental
- Price
- JHI $14.22
- RPID $3.05
- Analyst Decision
- JHI
- RPID Strong Buy
- Analyst Count
- JHI 0
- RPID 2
- Target Price
- JHI N/A
- RPID $8.00
- AVG Volume (30 Days)
- JHI 29.5K
- RPID 70.7K
- Earning Date
- JHI 01-01-0001
- RPID 10-31-2025
- Dividend Yield
- JHI 6.80%
- RPID N/A
- EPS Growth
- JHI N/A
- RPID N/A
- EPS
- JHI 1.05
- RPID N/A
- Revenue
- JHI N/A
- RPID $30,289,000.00
- Revenue This Year
- JHI N/A
- RPID $16.63
- Revenue Next Year
- JHI N/A
- RPID $21.98
- P/E Ratio
- JHI $12.47
- RPID N/A
- Revenue Growth
- JHI N/A
- RPID 22.57
- 52 Week Low
- JHI $11.63
- RPID $0.83
- 52 Week High
- JHI $13.40
- RPID $4.50
- Technical
- Relative Strength Index (RSI)
- JHI 51.62
- RPID 55.56
- Support Level
- JHI $14.14
- RPID $2.63
- Resistance Level
- JHI $14.46
- RPID $3.52
- Average True Range (ATR)
- JHI 0.12
- RPID 0.23
- MACD
- JHI -0.01
- RPID 0.09
- Stochastic Oscillator
- JHI 30.95
- RPID 62.04
About JHI John Hancock Investors Trust
John Hancock Investors Trust is a United States-based diversified, closed-end management investment company. It seeks to generate income for distribution to its shareholders. The secondary objective of the company is capital appreciation. The portfolio composition of the fund comprises corporate bonds, U.S. government agencies, preferred securities, asset-backed securities, common stocks, short-term investments, and others.
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.